Related Experiment Videos

The effect of long-term opiate antagonist administration to pubertal boys

H E Kulin1, L M Demers, A D Rogol

  • 1Department of Pediatrics, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.

Journal of Andrology
|November 1, 1987
PubMed

Insights

This study investigated if opiates influence puberty onset in boys. Naltrexone, an opiate antagonist, did not stimulate gonadotropin release, suggesting opiates do not control pubertal onset.

Area of Science:

  • Endocrinology
  • Adolescent Medicine
  • Neuroscience

Background:

  • Opiate pathways are hypothesized to influence gonadotropin production during puberty.
  • Understanding these pathways is crucial for adolescent reproductive health.

Purpose of the Study:

  • To investigate the role of opiatergic pathways in controlling gonadotropin production during early to mid-adolescence.
  • To determine if opiate antagonism affects pubertal onset in boys.

Main Methods:

  • Nine pubertal boys (bone age 10-15) received naltrexone (opiate antagonist) for up to 4 weeks.
  • Urinary gonadotropin levels (FSH, LH) were measured before, during, and after naltrexone administration.
  • Gonadotropin-releasing hormone (LRH) testing was performed in a subset of participants.

Main Results:

  • No significant stimulatory response in follicle-stimulating hormone (FSH) or luteinizing hormone (LH) was observed following naltrexone administration.
  • LRH testing also showed no evidence of opiate-mediated stimulation.

Conclusions:

  • The findings do not support a role for opiate-mediated mechanisms in the control of pubertal onset in males.
  • Opiatergic pathways do not appear to be functional in regulating gonadotropin production during early to mid-adolescence.

Related Concept Videos